The functional cytotoxic T lymphocyte–associated Protein 4 49G-to-A genetic variant and risk of pancreatic cancer

Authors

  • Ming Yang PhD,

    Corresponding author
    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    • College of Life Science and Technology, Beijing University of Chemical Technology, P. O. Box 53, Beijing 100029, China
    Search for more papers by this author
    • The first 2 authors contributed equally to this work.

    • Fax: (011) 86 10-64437610

  • Tong Sun MD,

    1. Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts
    Search for more papers by this author
    • The first 2 authors contributed equally to this work.

  • Yifeng Zhou PhD,

    1. Soochow University Laboratory of Cancer Molecular Genetics, School of Basic Medicine and Biological Sciences, Medical College of Soochow University, Suzhou, China
    Search for more papers by this author
  • Li Wang MD,

    1. Department of Epidemiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Search for more papers by this author
  • Li Liu MS,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Xiaojiao Zhang MS,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Xiaohu Tang MS,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Mo Zhou MS,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Pengqun Kuang PhD,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Wen Tan MD,

    1. Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Search for more papers by this author
  • Hui Li MD,

    1. Department of Epidemiology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    Search for more papers by this author
  • Qipeng Yuan PhD,

    1. College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China
    Search for more papers by this author
  • Dianke Yu PhD

    Corresponding author
    1. Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
    • Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China
    Search for more papers by this author
    • Fax: (011) 86 10-67722460


Abstract

BACKGROUND:

Antitumor T lymphocytes play an essential part in immune surveillance of cancer cells. Cytotoxic T lymphocyte–associated Protein 4 (CTLA-4) is a negative regulator of T cell activation and proliferation and therefore influences immune surveillance of carcinogenesis of pancreas. Thus, this study examined the association between functional CTLA-4 49G-to-A (49G>A) single-nucleotide polymorphism and pancreatic cancer risk.

METHODS:

Genotypes were determined in 368 patients with pancreatic cancer and 926 controls, and odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by logistic regression.

RESULTS:

A significant increased risk of pancreatic cancer was found to be associated with the CTLA-4 49G>A single-nucleotide polymorphism. Compared with noncarriers, the OR of developing pancreatic cancer for CTLA-4 49 GA or AA carriers was 1.75 (95% CI = 1.34-2.30, P = 4.83 × 10−5) or 2.54 (95% CI = 1.67-3.87, P = 1.36 × 10−5), respectively. In stratified analyses, the association was more pronounced in GA and AA carriers aged ≤60 years (OR = 3.10, 95% CI = 2.15-4.47, Pinteraction = .002), smokers with GA and AA genotypes (OR = 3.92, 95% CI = 2.39-6.43, Pinteraction = .037), and drinkers with GA and AA genotypes (OR = 4.55, 95% CI = 2.65-7.82, Pinteraction = .042), compared with GG carriers. Moreover, a supermultiplicative interaction between the CTLA-4 49AA genotype and smoking plus drinking was also evident in intensifying risk of pancreatic cancer (Pinteraction = 5.64 × 10−12).

CONCLUSIONS:

These results suggest that CTLA-4 49G>A polymorphism is involved in susceptibility to developing pancreatic cancer, alone and in a gene–environment interaction manner. Cancer 2012. © 2012 American Cancer Society.

Ancillary